Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
COMPLETED
NCT01149525
PHASE3

Efficacy of L-carnitine Versus Placebo in the Treatment of Fatigue in Multiple Sclerosis

Sponsor: University Hospital, Bordeaux

View on ClinicalTrials.gov

Summary

The objective of this study is to evaluate the efficacy of L-carnitine versus placebo in the treatment of fatigue in multiple sclerosis patients. This study will randomize 60 patients in a cross-over design. This study is sponsored by academic French health institutions.

Official title: A Randomised, Double Blinded Cross-over Study Comparing the Efficacy of L-carnitine Versus Placebo in the Treatment of Fatigue in Multiple Sclerosis

Key Details

Gender

All

Age Range

18 Years - Any

Study Type

INTERVENTIONAL

Enrollment

59

Start Date

2010-06

Completion Date

2013-07

Last Updated

2026-05-12

Healthy Volunteers

No

Interventions

DRUG

L-Carnitine

2g oral solution , twice per day (morning/evening), during 3 months

DRUG

Placebo

oral solution, twice per day (morning/evening), during 3 months

Locations (6)

University Hospital, Hospital Pellegrin

Bordeaux, France

University Hospital

Fort de France, France

University Hospital, Hospital Dupuytren

Limoges, France

University Hospital, Hospital Central

Nancy, France

University Hospital, Hospital Laënnec

Nantes, France

University Hospital, Hospital Pasteur

Nice, France